Fundraising Fox

Heiner Dreismann

Investor

Dr. at Cambridge Innovation Capital

About

Heiner Dreismann holds a master of science in biology and a PhD in microbiology/molecular biology from Westfaelische Wilhelms University in Muenster, Germany, and completed a post-doctoral fellowship at the French Center for Nuclear Research in Saclay. Early in his career he led genetic research and development at Roehm and Haas in Darmstadt, later joining F. Hoffmann La Roche AG where he held various management roles, including President and CEO of Roche Molecular Systems in Pleasanton, California, from 2000 to 2006. He currently sits on the boards of several public and private life sciences and healthcare companies across the United States, Europe, and Israel.

Invests in

BiotechHealthtech

Colleagues at Cambridge Innovation Capital

Frequently asked questions

Who is Heiner Dreismann?
Heiner Dreismann holds a master of science in biology and a PhD in microbiology/molecular biology from Westfaelische Wilhelms University in Muenster, Germany, and completed a post-doctoral fellowship at the French Center for Nuclear Research in Saclay. Early in his career he led genetic research and development at Roehm and Haas in Darmstadt, later joining F. Hoffmann La Roche AG where he held various management roles, including President and CEO of Roche Molecular Systems in Pleasanton, California, from 2000 to 2006. He currently sits on the boards of several public and private life sciences and healthcare companies across the United States, Europe, and Israel.
Where does Heiner Dreismann work?
Heiner Dreismann is Dr. at Cambridge Innovation Capital.
What does Heiner Dreismann invest in?
Heiner Dreismann invests in Biotech, Healthtech.